Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine
Clinical trial NCT01767896 · COMPLETED
Trial details
- NCT number
- NCT01767896
- Sponsor
- UMN Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-03-01
- Enrollment
- 1020
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.